Colon Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Colon Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) [Phase 3]
Phase 3 clinical trial evaluating Calderasib (MK-1084) in combination with targeted therapy and chemotherapy for colorectal cancer is curren…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Young-Onset Colorectal Cancer
MD Anderson Cancer Center-sponsored trial NCT02863107 for young-onset colorectal cancer is currently active but not recruiting. The listed c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas [Phase 1]
Phase 1 trial evaluating ctDNA-guided changes in therapy for patients with refractory minimal residual disease in colon adenocarcinoma. The …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma [Phase 2]
Phase 2 clinical trial update for Tolecizumab in combination with chemoimmunotherapy for pMMR/MSS locally advanced colon adenocarcinoma. The…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: COLON ERDERLY LOW DOSE
Clinical trial update indicates a colon adenocarcinoma study is not yet recruiting. The sponsor listed is Matteo Clavarezza.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Optimization of Adaptive Text Messages for Cancer Survivors (OATS II) [NA]
This update notes the completion of the OATS II trial evaluating adaptive text messaging for cancer survivors, with results posted on 2026-0…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a triple combination of encorafenib, cetuximab, and nivolumab in patients with microsatellite-stabl…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma [NA]
A clinical trial is evaluating sentinel lymph node biopsy and organ-sparing surgical approaches for stage I colon cancer; recruitment is ong…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: xDRIVE in Metastatic Colorectal Cancer
The clinical trial update indicates the xDRIVE therapy for metastatic colorectal cancer is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Family Communications After Genetic Testing [NA]
A NOT_YET_RECRUITING clinical trial update from the Alliance for Clinical Trials in Oncology studying family communications after genetic te…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Ultrasonic Versus Conventional Clipping Hemostasis in Laparoscopic Colorectal Surgery [NA]
This study compares ultrasonic versus conventional clipping hemostasis during laparoscopic colorectal surgery for colon adenocarcinoma and i…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
A pilot study is evaluating Mainz Biomed Colorectal Cancer Test for detecting colorectal cancer and advanced adenoma. The study is currently…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer [Phase 3]
Phase 3 trial evaluating oxaliplatin, leucovorin, and fluorouracil with or without bevacizumab as adjuvant therapy after surgery for Stage I…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab [Phase 2]
A Phase 2 study (MoLiMoR) evaluated first-line FOLFIRI-based therapy with or without intermittent cetuximab in colon and rectal adenocarcino…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]
Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery [Phase 2, Phase 3]
A Phase 2/3 trial evaluates circulating tumor DNA testing to predict and guide adjuvant treatment decisions for patients with Stage IIA colo…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer [Phase 2]
A Phase 2 clinical trial is evaluating an HDAC inhibitor in combination with chemoimmunotherapy as neoadjuvant treatment for pMMR locally ad…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability [Phase 1, Phase 2]
Phase 1/2 clinical trial results for bintrafusp alfa (M7824) in metastatic colorectal cancer and MSI-H advanced solid tumors have been poste…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer [Phase 2]
Phase 2 clinical trial update evaluating panitumumab, regorafenib, and TAS-102 in patients with metastatic and/or unresectable RAS wild-type…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer [Phase 2]
Phase 2 trial investigating savolitinib for MET-amplified metastatic or unresectable colorectal cancer was terminated with results posted.
-
CLINICAL_TRIALS research · 2021-03-30Clinical Trial Update: Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy [NA]
Clinical trial update on oxaliplatin microdosing assay to predict exposure and sensitivity to oxaliplatin-based chemotherapy in colon adenoc…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial [Phase 2]
Phase II trial evaluating combined neoadjuvant systemic therapy with PIPAC for colorectal peritoneal metastasis in patients eligible for CRS…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating nintedanib with capecitabine in refractory metastatic colorectal cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer [Phase 3]
Phase 3 trial evaluating FOLFIRI with or without bevacizumab in patients after surgery for stage II/III colon cancer; results posted in 2012…